These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 26256981)

  • 1. Changes of Heart Rate Variability during Methylphenidate Treatment in Attention-Deficit Hyperactivity Disorder Children: A 12-Week Prospective Study.
    Kim HJ; Yang J; Lee MS
    Yonsei Med J; 2015 Sep; 56(5):1365-71. PubMed ID: 26256981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate variability and methylphenidate in children with ADHD.
    Buchhorn R; Conzelmann A; Willaschek C; Störk D; Taurines R; Renner TJ
    Atten Defic Hyperact Disord; 2012 Jun; 4(2):85-91. PubMed ID: 22328340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
    Lee MS; Yang JW; Ko YH; Han C; Kim SH; Lee MS; Joe SH; Jung IK
    Child Psychiatry Hum Dev; 2008 Jun; 39(2):201-9. PubMed ID: 17763937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
    CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate-osmotic-controlled release oral delivery system treatment reduces parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder.
    Hwang JW; Kim B; Kim Y; Kim TH; Seo WS; Shin DW; Woo YJ; Yoo H; Lee JS; Lee JH; Lim MH; Chung YC; Jung CH; Yoo HK
    Hum Psychopharmacol; 2013 Nov; 28(6):600-7. PubMed ID: 24519694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol-O-methyltransferase Val158-Met polymorphism and a response of hyperactive-impulsive symptoms to methylphenidate: A replication study from South Korea.
    Park S; Kim JW; Kim BN; Shin MS; Yoo HJ; Cho SC
    J Psychopharmacol; 2014 Jul; 28(7):671-6. PubMed ID: 24763183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
    Balázs J; Dallos G; Keresztény A; Czobor P; Gádoros J
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of response time as a predictor of methylphenidate treatment response in korean children with attention deficit hyperactivity disorder.
    Lee SH; Song DH; Kim BN; Joung YS; Ha EH; Cheon KA; Shin YJ; Yoo HJ; Shin DW
    Yonsei Med J; 2009 Oct; 50(5):650-5. PubMed ID: 19881968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
    Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
    Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.
    Goez HR; Scott O; Nevo N; Bennett-Back O; Zelnik N
    J Child Neurol; 2012 Dec; 27(12):1547-52. PubMed ID: 22447850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained attention and heart rate variability in children and adolescents with ADHD.
    Griffiths KR; Quintana DS; Hermens DF; Spooner C; Tsang TW; Clarke S; Kohn MR
    Biol Psychol; 2017 Mar; 124():11-20. PubMed ID: 28099875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.